Liberty Biopharma Inc (CVE:LTY – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.
Liberty Biopharma Price Performance
The firm has a market cap of C$21.54 million and a PE ratio of -12.66. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19. The stock has a 50 day moving average price of C$2.00 and a two-hundred day moving average price of C$2.00.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Further Reading
- Five stocks we like better than Liberty Biopharma
- What Are Growth Stocks and Investing in Them
- CAVA Stock Looking for Direction After Earnings Miss
- What Does Downgrade Mean in Investing?
- 3 Small AI Stocks Ready to Explode (All Under $20)
- Quiet Period Expirations Explained
- After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
